(Q37890981)

24 August 2017

title

Does absolute neutrophil count predict high tumor grade in African-American men with prostate cancer? (English)

1 reference

24 August 2017

Neda Sadeghi

1

1 reference

24 August 2017

Gina M Badalato

2

1 reference

24 August 2017

Gregory Hruby

3

1 reference

24 August 2017

Victor Grann

4

1 reference

24 August 2017

James M McKiernan

5

1 reference

24 August 2017

publication date

16 June 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

72

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

386-391

1 reference

Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in the African-American population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

CYP3A4 genetic variant and disease-free survival among white and black men after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Multiple regions within 8q24 independently affect risk for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Neutropenia in 6 ethnic groups from the Caribbean and the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Benign ethnic neutropenia: what is a normal absolute neutrophil count?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

The Duffy Antigen/Receptor for Chemokines (DARC) and prostate-cancer risk among Jamaican men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

NF-kappaB: linking inflammation and immunity to cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Polymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Inhibition of macrophage- and neutrophil-mediated cytotoxicity by verapamil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Independent contributions of GR-1+ leukocytes and Fas/FasL interactions to induce apoptosis following interleukin-12 gene therapy in a metastatic model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Clinical and immunological characteristics of patients with serologic progression of prostate cancer achieving long-term disease control with granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Neutropenia enhances lung dendritic cell recruitment in response to Aspergillus via a cytokine-to-chemokine amplification loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Emerging roles of chemokines in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

CCL2 is a potent regulator of prostate cancer cell migration and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21440

21 January 2018

Identifiers

DOI

10.1002/PROS.21440

1 reference

24 August 2017

1 reference